Other studies have identified CXCR3, CXCR6, and CCR5 as other potential mediators of immune cell trafficking to the lungs during COVID-19 infection (80, 81), and one of these studies also demonstrated that T and NK cells that expressed these receptors in COVID-19 patients showed greater signs of activation (80). This evidence concerns the gene CXCR3 and COVID-19.